Subsidiary13 Aug 2026, 04:23 pm
Aurobindo Pharma Incorporates New Wholly Owned Subsidiary
AI Summary
Aurobindo Pharma Ltd has announced the incorporation of a new wholly owned subsidiary, 'Auropharm Overseas Limited', in India. The subsidiary was incorporated on August 13, 2026, with an initial share capital subscription of ₹10,00,000 in cash. Auropharm Overseas Limited is established to undertake manufacturing and marketing operations both domestically and internationally. This move signifies Aurobindo Pharma's strategic expansion into new operational territories.
Key Highlights
- Aurobindo Pharma incorporated a new wholly owned subsidiary, Auropharm Overseas Limited.
- The subsidiary will focus on manufacturing and marketing operations.
- Initial investment is ₹10,00,000 in cash for 100% shareholding.
- The subsidiary is incorporated in India.
- No governmental or regulatory approvals were required for incorporation.
Price Impact
More from AUROPHARMA